CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
59
AB Quote, Financials, Valuation and Earnings
Last price:
$41.05
Seasonality move
:
2.5%
Day range:
$40.04 - $40.75
52-week range:
$30.57 - $41.86
Dividend yield:
8.29%
P/E ratio:
10.81x
P/S ratio:
9.91x
P/B ratio:
2.23x
Volume:
355.7K
Avg. volume:
569.4K
1-year change:
21.25%
Market cap:
$4.4B
Revenue:
$461.9M
EPS (TTM):
$3.72
Analysts' Opinion
-
Consensus RatingAllianceBernstein Holding LP has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 5 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $37.64, AllianceBernstein Holding LP has an estimated downside of -6.29% from its current price of $40.17.
-
Price Target UpsideAccording to analysts, the highest upside price target is $40.50 representing -100% upside increase from its current price of $40.17.
Fair Value
-
According to the consensus of 6 analysts, AllianceBernstein Holding LP has -6.29% downside to fair value with a price target of $37.64 per share.
AB vs. S&P 500
-
Over the past 5 trading days, AllianceBernstein Holding LP has overperformed the S&P 500 by 4.35% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
AllianceBernstein Holding LP does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AllianceBernstein Holding LP revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter AllianceBernstein Holding LP reported revenues of $82.8M.
Earnings Growth
-
AllianceBernstein Holding LP has grown year-over-year earnings for 4 quarters straight. In the most recent quarter AllianceBernstein Holding LP reported earnings per share of $0.67.
Enterprise value:
4.4B
EV / Invested capital:
2.23x
Price / LTM sales:
9.91x
EV / EBIT:
9.70x
EV / Revenue:
9.70x
PEG ratio (5yr expected):
0.18x
EV / Free cash flow:
12.08x
Price / Operating cash flow:
12.34x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
20.43%
Net Income Margin (TTM):
91.66%
Return On Equity:
20.44%
Return On Invested Capital:
20.44%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $287.5M | $309.7M | $458.4M | $86.3M | $82.8M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.43 | $2.33 | $3.72 | $0.59 | $0.67 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.6B | $1.6B | $2.1B | $2.1B | $2B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.7M | $994K | $1.2M | $389K | $258K | |
| Total Equity | $1.6B | $1.6B | $2.1B | $2.1B | $2B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $313.5M | $303.7M | $368.1M | $87.7M | $115.3M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -$311.7M | -$303.7M | -$368.1M | -$87.7M | -$115.3M | |
| Free Cash Flow | $313.5M | $303.7M | $368.1M | $87.7M | $115.3M | |
AB
Sector
Market Cap
$4.4B
$597.2M
Price % of 52-Week High
95.96%
84.88%
Dividend Yield
8.29%
2.02%
Shareholder Yield
--
3.99%
1-Year Price Total Return
21.25%
7.66%
Beta (5-Year)
0.856
0.589
Dividend yield:
8.29%
Annualized payout:
$2.98
Payout ratio:
87.83%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$39.81
200-day SMA
Buy
Level
$36.35
Bollinger Bands (100)
Buy
Level
35.82 - 39.04
Chaikin Money Flow
Buy
Level
23.3M
20-day SMA
Buy
Level
$37.85
Relative Strength Index (RSI14)
Buy
Level
59.73
ADX Line
Buy
Level
18.1
Williams %R
Neutral
Level
-27.6596
50-day SMA
Buy
Level
$37.71
MACD (12, 26)
Buy
Level
0.92
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
24.8M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (2.9264)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (41%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of October 2024, AB had $793 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (42%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.
Stock Forecast FAQ
In the current month, AB has received 1 Buy ratings 5 Hold ratings, and 0 Sell ratings. The AB average analyst price target in the past 3 months is $37.64.
-
Where Will AllianceBernstein Holding LP Stock Be In 1 Year?
According to analysts, the consensus estimate is that AllianceBernstein Holding LP share price will drop to $37.64 per share over the next 12 months.
-
What Do Analysts Say About AllianceBernstein Holding LP?
Analysts are divided on their view about AllianceBernstein Holding LP share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AllianceBernstein Holding LP is a Sell and believe this share price will rise from its current level to $33.00.
-
What Is AllianceBernstein Holding LP's Price Target?
The price target for AllianceBernstein Holding LP over the next 1-year time period is forecast to be $37.64 according to 6 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is AB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AllianceBernstein Holding LP is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AB?
You can purchase shares of AllianceBernstein Holding LP via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AllianceBernstein Holding LP shares.
-
What Is The AllianceBernstein Holding LP Share Price Today?
AllianceBernstein Holding LP was last trading at $41.05 per share. This represents the most recent stock quote for AllianceBernstein Holding LP. Yesterday, AllianceBernstein Holding LP closed at $40.17 per share.
-
How To Buy AllianceBernstein Holding LP Stock Online?
In order to purchase AllianceBernstein Holding LP stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
